Raymond E. Cabillot Sells 2,784 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 2,784 shares of Pro-Dex stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $50.00, for a total value of $139,200.00. Following the completion of the sale, the director now owns 295,810 shares in the company, valued at approximately $14,790,500. The trade was a 0.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Pro-Dex Price Performance

Pro-Dex stock opened at $49.41 on Thursday. The company has a fifty day simple moving average of $40.02 and a 200-day simple moving average of $39.68. The firm has a market capitalization of $161.13 million, a price-to-earnings ratio of 24.58 and a beta of 0.68. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.33. Pro-Dex, Inc. has a 52-week low of $16.84 and a 52-week high of $59.60.

Pro-Dex (NASDAQ:PDEX) last announced its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. On average, equities analysts anticipate that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Pro-Dex from a “buy” rating to a “hold” rating in a research report on Wednesday, March 12th.

Institutional Investors Weigh In On Pro-Dex

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Northern Trust Corp boosted its stake in Pro-Dex by 14.1% during the fourth quarter. Northern Trust Corp now owns 35,754 shares of the medical instruments supplier’s stock worth $1,672,000 after buying an additional 4,426 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Pro-Dex by 9.1% during the 3rd quarter. Geode Capital Management LLC now owns 27,435 shares of the medical instruments supplier’s stock valued at $819,000 after acquiring an additional 2,296 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Pro-Dex by 2.2% in the third quarter. JPMorgan Chase & Co. now owns 24,790 shares of the medical instruments supplier’s stock valued at $740,000 after purchasing an additional 529 shares during the period. EAM Investors LLC acquired a new stake in Pro-Dex during the fourth quarter worth about $1,047,000. Finally, O Shaughnessy Asset Management LLC purchased a new position in Pro-Dex during the fourth quarter worth about $995,000. Institutional investors and hedge funds own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.